Research Study

A Randomized, Parallel-group, Double-blind, Placebo-controlled, Multi-center Study of Eculizumab for the Prevention of Delayed Graft Function After Kidney Transplantation in Adult Subjects at Increased Risk of Delayed Graft Function
Principal Investigator 
John Gill

Overview

Body Locations and Systems 
Kidney Transplantation
Diagnosis and Therapy 
Kidney Transplantation
ClinicalTrials.gov# 
NCT02145182
Status 
Closed to Recruitment
Study Start/End 
Aug 6, 2014 to Dec 31, 2016
Locations 
St. Paul's Hospital, Vancouver General Hospital
Name/Title 
Jesmint Dhillon, Study Coordinator
Phone 
604-682-2344 ext.64708
Purpose of Study 

The purpose of this study is to determine if Eculizumab is safe and could be used to prevent delayed graft function following kidney transplantation.

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician.